Werewolf Therapeutics Inc (NASDAQ: HOWL) is -37.91% lower on its value in year-to-date trading and has touched a low of $0.60 and a high of $6.89 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HOWL stock was last observed hovering at around $0.85 in the last trading session, with the day’s gains setting it 0.07%.
Currently trading at $0.92, the stock is 5.35% and -18.15% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.16 million and changing 8.37% at the moment leaves the stock -49.27% off its SMA200. HOWL registered -83.62% loss for a year compared to 6-month loss of -54.28%. The firm has a 50-day simple moving average (SMA 50) of $1.12284 and a 200-day simple moving average (SMA200) of $1.81146.
The stock witnessed a -18.67% gain in the last 1 month and extending the period to 3 months gives it a -31.42%, and is 40.52% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.91% over the week and 11.96% over the month.
Werewolf Therapeutics Inc (HOWL) has around 46 employees, a market worth around $41.19M and $1.89M in sales. Profit margin for the company is -3740.85%. Distance from 52-week low is 54.45% and -86.66% from its 52-week high. The company has generated returns on investments over the last 12 months (-64.74%).
with sales reaching $300k over the same period.The EPS is expected to shrink by -6.13% this year, but quarterly earnings will post -36.34% year-over-year. Quarterly sales are estimated to shrink -59.57% in year-over-year returns.
100.0 institutions hold shares in Werewolf Therapeutics Inc (HOWL), with institutional investors hold 67.39% of the company’s shares. The shares outstanding are 44.83M, and float is at 33.13M with Short Float at 5.91%. Institutions hold 63.30% of the Float.
The top institutional shareholder in the company is RA CAPITAL MANAGEMENT, L.P. with over 6.14 million shares valued at $14.99 million. The investor’s holdings represent 14.7688 of the HOWL Shares outstanding. As of 2024-06-30, the second largest holder is MPM ASSET MANAGEMENT LLC with 4.28 million shares valued at $10.45 million to account for 10.2967 of the shares outstanding. The other top investors are PFM HEALTH SCIENCES, LP which holds 3.24 million shares representing 7.7897 and valued at over $7.91 million, while BIOIMPACT CAPITAL LLC holds 5.7394 of the shares totaling 2.39 million with a market value of $5.83 million.
